Search Results - "Stornaiuolo, G"

DAA-based regimens in HBsAg/anti-HCV positive patients: the need to control HBV replication to avoid HBV reactivation by Coppola, N, Stanzione, M, Messina, V, D’Adamo, G, Sangiovanni, V, Fontanella, L, De Pascalis, S, Stornaiuolo, G, Macera, M, Piai, G, Gaeta, G, Gentile, I

Get full text

DAA-based regimens in HBsAg/anti-HCV positive patients: The need to control HBV replication to avoid HBV reactivation by Macera, M, Stanzione, M, Messina, V, D’Adamo, G, Sangiovanni, V, Fontanella, L, De Pascalis, S, Stornaiuolo, G, Piai, G, Gaeta, G.B, Gentile, I, Coppola, N

Get full text

Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA by Colagrossi, L, Salpini, R, Scutari, R, Battisti, A, Piermatteo, L, Bertoli, A, Menichini, C, Trimoulet, P, Fleury, H, Nebuloso, E, De Cristofaro, M, Cappiello, G, Spanò, A, Malagnino, V, Mari, T, Barlattani, A, Iapadre, N, Lichtner, M, Mastroianni, C.M, Lenci, I, Pasquazzi, C, De Sanctis, G.M, Lanza, A.G, Stanzione, M, Stornaiuolo, G, Marignani, M, Sarmati, L, Andreoni, M, Angelico, M, Perno, C.F, Coppola, N, Svicher, V

Get full text

HBV-HDV Co-Infection Constrains HBV Genetic Evolution in HBsAg by Colagrossi, L, Scutari, R, Battisti, A, Salpini, R, Pollicita, M, Bertoli, A, Minichini, C, Trimoulet, P, Fleury, H, Nebuloso, E, Longo, R, Cappiello, G, Spanó, A, Malagnino, V, Sarmati, L, Mari, T, Barlattani, A, Iapadre, N, Lichtner, M, Mastroianni, C, Lenci, I, Baiocchi, L, Pasquazzi, C, De Sanctis, G.M, Lanza, A.G, Stanzione, M, Stornaiuolo, G, Marignani, M, Andreoni, M, Angelico, M, Perno, C.-F, Coppola, N, Svicher, V

Get full text

An elevated degree of genetic variability characterizes Hepatitis Delta Antigen (HDAg) and correlates with high levels of serum HDV-RNA: Implication for disease progression and design of new pharmacological targets by Colagrossi, L, Salpini, R, Scutari, R, Battisti, A, Piermatteo, L, Bertoli, A, Minichini, C, Trimoulet, P, Fleury, H, Nebuloso, E, De Cristofaro, M, Cappiello, G, Spanò, A, Malagnino, V, Mari, T, Barlattani, A, Iapadre, N, Lichtner, M, Mastroianni, C.M, Lenci, I, Pasquazzi, C, De Sanctis, G.M, Galeota Lanza, A, Stanzione, M, Stornaiuolo, G, Marignani, M, Sarmati, L, Andreoni, M, Angelico, M, Perno, C.F, Coppola, N, Svicher, V

Get full text

HBV-HDV co-infection constrains HBV genetic evolution in HBsAg by Colagrossi, L, Scutari, R, Salpini, R, Battisti, A, Pollicita, M, Bertoli, A, Minichini, C, Trimoulet, P, Fleury, H, Nebuloso, E, De Cristofaro, M, Cappiello, G, Spanò, A, Malagnino, V, Sarmati, L, Mari, T, Barlattani, A, Iapadre, N, Lichtner, M, Mastroianni, C, Lenci, I, Baiocchi, L, Pasquazzi, C, Sanctis, G. Maria De, Lanza, A.G, Stanzione, M, Stornaiuolo, G, Marignani, M, Andreoni, M, Angelico, M, Perno, C.F, Coppola, N, Svicher, V

Get full text

390 ACTIVE IN-THE-FIELD SURVEILLANCE REVEALS HIGH RATES OF HEPATITIS AND HIV COINFECTIONS AMONG AN IMMIGRANT POPULATION by Stornaiuolo, G, Cuniato, V, Cuomo, G, Nocera, E, Brancaccio, G, De Rosa, M, Natale, R.F, Gaeta, G.B

Get full text

715 ASSESSMENT OF THE VIROLOGICAL PROFILES OF UNTREATED PATIENTS WITH CHRONIC HEPATITIS DELTA (CHD) REQUIRES LONGITUDINAL MEASUREMENTS OF HBV DNA AND HDV RNA by Brancaccio, G, Madejon, A, Stornaiuolo, G, Cuomo, G, Soriano, V, Gaeta, G.B

Get full text

Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in ‘real world’ patients with chronic hepatitis C by Gaeta, G. B., Precone, D. F., Felaco, F. M., Bruno, R., Spadaro, A., Stornaiuolo, G., Stanzione, M., Ascione, T., De Sena, R., Campanone, A., Filice, G., Piccinino, F.

“…SUMMARY Background : Interferon‐α plus ribavirin therapy for chronic hepatitis C is associated with adverse effects that lead to therapy discontinuation in up…”
Get full text

1003 INTRAHEPATIC HBV STATUS AFTER 10 YEAR OF SUSTAINED VIRAL SUPPRESION BY LAM: ANALYSIS OF CCCDNA SEQUENCE AND EXPRESSION by Belloni, L, Brancaccio, G, Cimino, L, Stornaiuolo, G, Andreana, L, De Iaco, R, Guido, M, Levrero, M, Gaeta, G

Get full text

OC3 ACTIVE IN-THE-FIELD SURVEILLANCE REVEALS HIGH RATES OF HEPATITIS VIRUS AND HIV INFECTIONS AMONG AN IMMIGRANT POPULATION by Stornaiuolo, G, Cuniato, V, Cuomo, G, Nocera, E, Brancaccio, G, De Rosa, M, Natale, R.F, Gaeta, G.B

Get full text

OC-20 Prophylaxis of hepatitis B after liver transplantation: report of an Italian survey in a cohort of 2260 patients by Fasulo, R, Marzano, A, Salizzoni, M, Cocchis, D, Caccamo, L, Burra, P, Russo, P, Bertoluzzi, I, Fagiuoli, S, Verga, G, Colpani, M, Gaeta, G.B, Stornaiuolo, G, De Carlis, L, Mangoni, I, Zamboni, F, Mameli, L, Piras, M.R, Boccagni, P, Toniutto, P, Lenisa, I, Tamè, M.R, Andreone, P, Vukotic, R, Iemmolo, R.M, Caporaso, N, Parrilli, G, Coppola, C, Masculo, M.C, Conoscitore, P, Volpes, R, Forte, P, Caneschi, F, Vennarecci, G, Tisone, G, Anselmo, A, Merli, M, Giannelli, V, Piai, G, Francavilla, R, Lotti, A.M

Get full text

Innate and Acquired Immune System in Patients Developing Interferon-α-Related Autoimmune Thyroiditis: A Prospective Study by Mazziotti, G., Sorvillo, F., Piscopo, M., Morisco, F., Cioffi, M., Stornaiuolo, G., Gaeta, G. B., Molinari, A. M., Lazarus, J. H., Amato, G., Carella, C.

“…Objective: In this prospective study, we investigated whether the development of interferon (IFN)-α-related autoimmune thyroiditis (IFN-AT) was correlated with…”
Get full text

Adefovir dipivoxil-associated thrombocytopenia in a patient with chronic hepatitis B by Stornaiuolo, G., Amato, A., Gaeta, G.B.

“…A 56-year-old male patient received adefovir dipivoxil (10 mg/day) for chronic hepatitis B resistant to lamivudine. On the fifth week of treatment, the…”
Get full text

Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: A prospective study by MAZZIOTTI, G, SORVILLO, F, CARELLA, C, STORNAIUOLO, G, ROTONDI, M, MORISCO, F, RUBERTO, M, CIOFFI, M, AMATO, G, CAPORASO, N, GAETA, G. B

“…In this prospective study we performed repeated evaluations of thyroid status in patients undergoing treatment with different preparations of recombinant…”
Get full text

Interferon-α plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study by Gaeta, G. B., Stornaiuolo, G., Stanzione, M., Ascione, T., Pasquazzi, C., Taliani, G., Cimino, L., Budillon, G., Piccinino, F.

“…The optimal therapy for patients with chronic hepatitis C who have not responded to interferon (IFN) is still an unsolved issue. The aim of this study was to…”
Get full text

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B by Lampertico, Pietro, Viganò, Mauro, Di Costanzo, Giovan Giuseppe, Sagnelli, Evangelista, Fasano, Massimo, Di Marco, Vito, Boninsegna, Sara, Farci, Patrizia, Fargion, Silvia, Giuberti, Tiziana, Iannacone, Claudio, Regep, Loredana, Massetto, Benedetta, Facchetti, Floriana, Colombo, Massimo

“…Treatment with peginterferon α-2a (PegIFN) for 48 weeks is the standard of care for selected HBeAg-negative patients chronically infected with hepatitis B…”
Get more information

SAT-248 - DAA-based regimens in HBsAg/anti-HCV positive patients: the need to control HBV replication to avoid HBV reactivation by Coppola, N., Stanzione, M., Messina, V., D’Adamo, G., Sangiovanni, V., Fontanella, L., De Pascalis, S., Stornaiuolo, G., Macera, M., Piai, G., Gaeta, G., Gentile, I.

Get full text

Quantitative Viremia Test for Early Prediction of a Biochemical Response in Patients with Chronic Hepatitis C Treated with Interferon by Nardiello, S., Gaeta, G.B., Pizzella, T., Ascione, G. Stornaiuolo T., Galanti, B., Giusti, G.

“…To evaluate the importance of the changes in viremia as an early predictor of the outcome of interferon (IFN) therapy, we assayed the levels of hepatitis C…”
Get full text

Virological patterns of hepatitis C virus patients with failure to the current-generation direct-acting antivirals by Pisaturo, M., Starace, M., Minichini, C., De Pascalis, S., Occhiello, L., Fraia, A. Di, Messina, V., Sangiovanni, V., Claar, E., Coppola, N.

“…•Few data on virological characterisation of patients with failure to current-generation direct-acting antivirals (DAAs).•Prevalence of resistance-associated…”
Get full text